An assay to quantify species-specific anti-JC virus antibody levels in MS patients
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An assay to quantify species-specific anti-JC virus antibody levels in MS patients
Authors
Keywords
-
Journal
Multiple Sclerosis Journal
Volume 19, Issue 9, Pages 1137-1144
Publisher
SAGE Publications
Online
2013-02-07
DOI
10.1177/1352458513475489
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dried Blood Spot Samples for Seroepidemiology of Infections with Human Papillomaviruses, Helicobacter pylori, Hepatitis C Virus, and JC Virus
- (2012) T. Waterboer et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Anti-JC-virus antibody prevalence in a German MS cohort
- (2012) Clemens Warnke et al. Multiple Sclerosis Journal
- Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort
- (2012) A. K. Trampe et al. NEUROLOGY
- Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
- (2012) Gary Bloomgren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-John Cunnigham virus antibody prevalence in multiple sclerosis patients: Baseline results of STRATIFY-1
- (2011) Carmen Bozic et al. ANNALS OF NEUROLOGY
- Age-Specific Seroprevalence of Merkel Cell Polyomavirus, BK Virus, and JC Virus
- (2011) Raphael P. Viscidi et al. Clinical and Vaccine Immunology
- The link between VLA-4 and JC virus reactivation
- (2011) Maria Chiara G Monaco et al. Expert Review of Clinical Immunology
- Multi-site analytical validation of an assay to detect anti-JCV antibodies in human serum and plasma
- (2011) Tatiana Plavina et al. JOURNAL OF CLINICAL VIROLOGY
- Epstein-Barr virus and multiple sclerosis
- (2011) R. M. Lucas et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring
- (2011) Ludwig Kappos et al. LANCET NEUROLOGY
- Risikostratifizierung einer progressiven multifokalen Leukenzephalopathie unter Natalizumab
- (2011) C. Warnke et al. NERVENARZT
- Anti-JC virus antibodies: Implications for PML Risk Stratification
- (2010) Leonid Gorelik et al. ANNALS OF NEUROLOGY
- Natalizumab and Progressive Multifocal Leukoencephalopathy
- (2010) Clemens Warnke et al. ARCHIVES OF NEUROLOGY
- Prevalence and stability of antibodies to the BK and JC polyomaviruses: a long-term longitudinal study of Australians
- (2010) A. Antonsson et al. JOURNAL OF GENERAL VIROLOGY
- Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases
- (2010) David B Clifford et al. LANCET NEUROLOGY
- Identification of species-specific and cross-reactive epitopes in human polyomavirus capsids using monoclonal antibodies
- (2009) P. Randhawa et al. JOURNAL OF GENERAL VIROLOGY
- Prevalence of Polyomavirus BK and JC Infection and Replication in 400 Healthy Blood Donors
- (2009) Adrian Egli et al. JOURNAL OF INFECTIOUS DISEASES
- Seroepidemiology of Human Polyomaviruses
- (2009) Jaime M. Kean et al. PLoS Pathogens
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now